Breviscapinun Powder 116122-36-2 Erigeron Breviscapus

Breviscapinun Powder 116122-36-2 Erigeron Breviscapus 

[Product Name]: Breviscapinun
[Apperance]: Yellow Powder
[Specification]: 98%
[Test Method]: HPLC
[Storage]: Store in a cool, dry place and sealed container.

Breviscapine is widely used in the treatment of ischemic cerebrovascular diseases including acute cerebral infarction, sequelae of cerebral infarction and vertebrobasilar artery insufficiency. It is also used in the treatment of cerebral arteriosclerosis and vascular dementia, alleviating secondary brain injury after traumatic brain injury and improving prognosis. Breviscapine also has good therapeutic effect on delayed encephalopathy caused by carbon monoxide poisoning. Breviscapine is also used in the treatment of angina pectoris, acute myocardial infarction, heart failure and hypertension. Breviscapine can delay the occurrence, reduce the severity and decrease the mortality of adrenaline induced arrhythmia in rats, suggesting that breviscapine may also have antagonistic effect on arrhythmia. Breviscapine is also widely used in clinical treatment of other diseases, including some complications of diabetes, chronic kidney disease, hypoxic pulmonary hypertension, chronic pulmonary heart disease, glaucoma, rheumatoid arthritis and liver damage. Recently, breviscapine has been used in the treatment of peptic ulcer and erythema nodosa, but the exact efficacy and mechanism remain to be further confirmed. In addition, a number of animal experiments have shown that breviscapine can accelerate the movement of orthodontic teeth, and the effect of ion introduction is more obvious than local injection, and the inflammatory reaction is less, which provides experimental basis for the new clinical application of breviscapine.

Our Hot Sales products are: Nattokinase Powder, Hawthorn Extract, Salvia Miltiorrhiza Extract, Notoginseng Extract and so on.